首页> 外文期刊>Mutation Research. Reviews in Mutation Research >Modulation of heterocyclic amine-induced mutagenicity and carcinogenicity: an 'A-to-Z' guide to chemopreventive agents, promoters, and transgenic models [Review]
【24h】

Modulation of heterocyclic amine-induced mutagenicity and carcinogenicity: an 'A-to-Z' guide to chemopreventive agents, promoters, and transgenic models [Review]

机译:杂环胺诱导的致突变性和致癌性的调节:化学预防剂,启动子和转基因模型的“ A至Z”指南[综述]

获取原文
获取原文并翻译 | 示例
           

摘要

A landmark report by Widmark in 1939 describing "cancer-producing substances in roasted food", and the seminal work of Sugimura and colleagues in the 1970s on the isolation of potent mutagens from cooked meat and fish stimulated a major international effort on the study of heterocyclic amines and their modulators. The latter term is used in its broadest context to mean agents or conditions that positively or negatively influence the mutagenic or carcinogenic activities of heterocyclic amines in vitro or in vivo. An 'A-to-Z' list of these modulators includes well over 150 natural or synthetic phytochemicals, micronutrients and antioxidants, as well as several large chemical classes (polyphenols, flavones, retinoids, porphyrins), food fractions, and food preparation methods. In many cases, the findings reported in the literature can be regarded as descriptive, but for a number of specific agents there is sufficient evidence to glean some understanding of the inhibitory or promotional mechanisms of action. These mechanisms can be divided into 11 separate sub-categories, arranged within a general classification scheme that encompasses such terms as 'blocking agents', 'suppressing agents', 'desmutagens', 'bioantimutagens', 'interceptor molecules' and 'tumor promoters'. In addition, new research directions, most notably during the past 2-3 years or so, have led to the use of novel dosing protocols and unique animal models (including transgenic species) that provide insight into exposure conditions and genetic background as modulators of heterocyclic amine activity in vitro and in vivo. Overall, the more than 250 citations on the subject give ample evidence of the growing interest in modulators of heterocyclic amine carcinogenesis and mutagenesis, and their possible importance in determining human cancer risk in defined populations. (C) 2002 Elsevier Science B.V. All rights reserved. [References: 269]
机译:威马克(Widmark)在1939年发表的具有里程碑意义的报告描述了“烧烤食品中产生癌症的物质”,杉村及其同事在1970年代关于从肉和鱼中分离有效诱变剂的开创性工作激发了国际上对杂环研究的重大努力。胺及其调节剂。后一术语在其最广泛的上下文中用于表示对体外或体内杂环胺的诱变或致癌活性具有正面或负面影响的作用剂或病症。这些调节剂的“从A到Z”列表包括远远超过150种天然或合成植物化学物质,微量营养素和抗氧化剂,以及几种较大的化学类别(多酚,黄酮,类维生素A,卟啉),食品级分和食品制备方法。在许多情况下,文献中报道的发现可被认为是描述性的,但是对于许多特定的药物,有足够的证据收集对抑制或促进作用机制的一些理解。这些机制可分为11个单独的子类别,排列在一个通用分类方案中,该分类方案包含诸如“阻断剂”,“抑制剂”,“去突变素”,“生物抗突变素”,“拦截分子”和“肿瘤启动子”之类的术语。 。此外,新的研究方向(最显着的是在过去的2-3年左右)已导致使用新颖的剂量方案和独特的动物模型(包括转基因物种)来提供对暴露条件和遗传背景的了解,作为杂环的调节剂在体外和体内的胺活性。总体而言,对该主题的250多次引用提供了充足的证据,表明人们对杂环胺致癌和诱变调节剂的兴趣日益增长,并且它们在确定特定人群中人类癌症风险中可能具有重要意义。 (C)2002 Elsevier Science B.V.保留所有权利。 [参考:269]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号